BSX Stock Analysis: Buy, Sell, or Hold?
BSX - Boston Scientific Corp.
$51.83
0.14 (0.27%)
▲
5d:
+5.11%
30d:
+16.16%
90d:
-3.21%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 7, 2026 at $49.31 · last confirmed Aug 14, 2026
Strength: 9.0/10
Get Alerted When BSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BSX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BSX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$76.32
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$47.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BSX is currently trading at $51.83, which is considered extended relative to its 30-day fair value range of $43.55 to $49.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.1) compared to its historical average (18.2). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This pessimistic expectation contrasts with the company's recent 15.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is approaching resistance at $52.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BSX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+21.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BSX is in a strong downtrend. The price is approaching resistance at $52.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BSX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+21.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$43.55 -
$49.25
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Protect Your Profits
BSX is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.2% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.0% below Wall St target ($62.69)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$43.55 -
$49.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$47.10
Resistance Level
$52.99
Current Trend
Strong Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.07
Wall Street Target
$62.69
(+21.0%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
15.1%
Profit Margin
17.5%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
15.1 vs 18.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$48.67
(-6%)
2-Year Target
$45.70
(-12%)
3-Year Target
$42.91
(-17%)
3-Yr Target (if PE normalizes)
(PE: 15→18)
$51.81
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 4.1%)
$78.43
(+51%)
Base:
(SPY PE: 15.1, Growth: 4.1%)
$58.44
(+13%)
Bear:
(PE: 12.8, Growth: 4.1%)
$49.68
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 20.84 | Current EPS (TTM): $2.48
Bull Case
$78.83
(+52%)
Analyst growth 38.6%, PE expands to 22.9
Base Case
$71.67
(+38%)
Market implied 38.6%, PE stable at 20.8
Bear Case
$35.15
(-32%)
Severe decline -20.0%, PE contracts to 17.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.1 to 18.2
Stabilization Target:
$62.58
(+20.7%)
PE Expansion Potential:
+20.7%
Share & Embed Analysis
Last updated: August 16, 2026 2:41 AM ET
Data refreshes hourly during market hours. Next update: 3:41 AM
Data refreshes hourly during market hours. Next update: 3:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BSX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
SELL
2026-02-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 28 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 41 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 39 SELL |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 37 SELL |
Advanced BSX Option Strategies
Professional options setups generated by AI based on today's BSX price and gamma walls.
